Acme United Corporation is a supplier of first aid, medical, cutting, and sharpening products serving school, home, office, hardware, sporting goods, and industrial markets. The company operates in two main segments: first aid and medical, and cutting and sharpening. Its first aid and medical portfolio includes brands such as First Aid Only, PhysiciansCare, Spill Magic, First Aid Central, Med-Nap, Safety Made, Elite, and My Medic, offering first aid kits, spill clean-up solutions, eyewash stations, and tactical trauma products. The cutting and sharpening segment features the Westcott brand for school and office items like scissors and rulers, and the Clauss and DMT brands for professional cutting tools and diamond sharpeners. Acme United sells through mass market retailers, e-commerce platforms, industrial distributors, and office supply stores. Operations are located in the United States, Canada, Germany, Hong Kong, and China, with manufacturing facilities in the U.S. and Canada. The company was organized as a partnership in 1867 and incorporated in 1882.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Household & Personal Products Homepage acmeunited.com
Sector Consumer Defensive IR page —
Tags
first aid kits, medical supplies, scissors, sharpening tools, spill absorbents, tactical trauma, office supplies, industrial safety, diamond abrasives, promotional products, First Aid Only, PhysiciansCare, Pac-Kit, Spill Magic, First Aid Central, Med-Nap, Safety Made, Elite, My Medic, Westcott, Clauss, DMT, Smart Compliance, SafetyHub App, SmartCompliance Complete, Spill Response System, EdgeSharp
Press page acmeunited.com/company/news

Metrics

Valuation  
Market cap $ 273.893M
Market cap (USD) $ 273.893M
P/E 25.38
PEG 0.51
P/BV 2.19
P/S 1.24
P/OCF 14.36
P/FCF 19.84
Dividend yield 0.03%
Turnover / mcap —
Returns  
ROE 9.1%
ROI 7.9%
ROIC 8.8%
Profit margin 5.2%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) 49.7%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) Yes
Debt/Equity 22.5%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 11
Quality score 5.6%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Revenue 196.542M 194.49M 191.501M 193.962M 182.088M 164.003M 142.457M 137.321M 130.55M 124.574M 109.812M 107.222M 89.577M 84.37M 73.302M 63.149M 59.149M 68.719M 63.173M 56.863M 49.946M 43.381M 34.975M 30.884M 36.165M 34.413M
Net profit 10.184M 10.022M 17.793M 3.035M 13.656M 8.099M 5.514M 4.598M 4.052M 5.851M 4.794M 4.789M 4.003M 3.549M 2.811M 2.573M 2.842M 4.467M 4.022M 3.886M 2.937M 3.238M 1.222M 659.494K 1.28M 1.061M
Free cash flow 7.578M 4.827M 24.226M -1.413M -1.232M 3.152M 13.022M 1.624M 1.665M 7.047M -676.994K 2.607M 1.884M -1.954M 1.122M -2.072M 6.015M 2.523M 2.033M -1.388M -1.869M 3.868M 1.328M 1.158M 1.741M 49.866K

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Share price 40.31 37.33 42.86 21.9 33.7 30.13 23.78 14.25 23.4 25.57 17.4 19.99 14.9 10.83 9.73 9.95 8.6 6.11 14.45 14.53 — 6.32 — — — —
Price performance 12m 0.08 -0.13 0.96 -0.35 0.12 0.27 0.67 -0.39 -0.08 0.47 -0.13 0.34 0.38 0.11 -0.02 0.16 0.41 -0.58 -0.01 — — — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 20M 26M 25.1M 25.5M 27.2M 34.2M 32.6M 26.2M 28.2M 29.1M
↳ YoY growth +2.3% +29.9% -3.5% +1.5% +6.6% +25.9% -4.7% -19.5% +7.6% +3.1%
↳ 5y CAGR +9.2% +9.6% +9.9% +5.5% +6.8% +11.3% +4.6% +0.9% +2.1% +1.4%
Borrowings, non-current (USD) 32.9M 43.5M 40.3M 33.2M 38.8M 33M 49.9M 13.1M 17.6M 11.9M
Lease liabilities (USD) — — — 3.01M 2.53M 3.36M 2.81M 2.13M 4.93M 6.98M
Cash and deposits (USD) 5.91M 9.34M 4.41M 6.82M 4.17M 4.84M 6.1M 4.8M 6.4M 3.6M
Intangible assets (USD) 14M 17.9M 17M 15.8M 18.7M 17.2M 20.8M 19M 20.3M 19.5M
Right-of-use assets (USD) — — 2.9M 2.99M 2.42M 3.13M 2.63M 2M 4.83M 6.88M
Net debt (borrowings + leases - cash) (USD) 27M 34.1M 35.9M 29.4M 37.1M 31.6M 46.6M 10.4M 16.1M 15.2M
Cash flow detail
Operating cash flow (USD) 8.86M 4.81M 4.48M 14.7M 5.72M 5.14M 2.89M 28.9M 12M 18.2M
Purchases of property, plant and equipment (USD) -1.81M -3.15M -2.85M -1.68M -2.57M -6.37M -4.3M -4.67M -7.15M -10.7M
Purchases of intangible assets (USD) -29,371 — -379,921 — — — -300,000 -301,736 — —
Change in receivables (cash effect) (USD) 499,940 -5.23M 807,988 -784,562 -2.03M -7.23M 1.84M 6.33M -2.46M -592,817
Change in inventories (cash effect) (USD) -1.48M -1.85M -1.58M 2.09M -10M -3.21M -9.61M 3.65M -329,896 -3.07M
Change in payables (cash effect) (USD) 610,498 3.73M -3.07M -1.53M 460,179 1.5M 1.91M 1.55M -2.98M -1.06M
Dividends paid (cash effect) (USD) -1.33M -1.41M -1.48M -1.61M -1.6M -1.79M -1.9M -1.99M -2.22M -2.34M
Interest paid (cash effect) (USD) -841,634 -1.26M -1.86M -1.86M -930,357 -908,781 -2.12M -3.18M -1.9M -1.57M
Income taxes paid (cash effect) (USD) -1.78M -1.57M -887,592 -422,339 -755,337 -874,996 -978,378 -5.77M -2.25M -560,723
Share-based compensation (USD) 440,536 684,351 869,055 968,467 1.26M 1.81M 1.8M 1.94M 2.18M 1.99M
Operating cash flow before change in receivables (USD) 8.36M 10M 3.67M 15.5M 7.75M 12.4M 1.05M 22.6M 14.4M 18.8M
Free cash flow (OCF - PPE - intangibles) (USD) 7.02M 1.66M 1.24M 13M 3.15M -1.23M -1.71M 23.9M 4.83M 7.58M
Income detail
Research and development expense (USD) 750,000 752,000 734,000 596,000 251,000 — — — — —
↳ 5y CAGR +7.0% +5.6% +4.0% -2.2% -18.3%
Total comprehensive income (USD) 6.05M 4.75M 4.17M 5.7M 9.26M 13.1M 2.33M 18.2M 8.98M 11.4M
Comprehensive income to owners (USD) 6.05M 4.75M 4.17M 5.7M 9.26M 13.1M 2.33M 18.2M 8.98M 11.4M
Provision for credit losses (USD) — — 156,000 290,128 778,869 — 199,996 -129,219 — —
Credit cost ratio (credit losses / average receivables) (%) — — 0.6% 1.1% 3.0% — 0.6% 0.4% — —
Reported Mar 10, 2017 Mar 15, 2018 Mar 13, 2020 Mar 13, 2020 Mar 31, 2021 Mar 30, 2022 Mar 10, 2023 Mar 7, 2024 Mar 6, 2025 Mar 11, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

ACME UNITED CORPORATION NEWS RELEASE Bull 3 Bear 0 Results

CONTACT: Paul G. Driscoll Acme United Corporation 1 Waterview Drive Shelton, CT 06484

Phone: (203) 254-6060

FOR IMMEDIATE RELEASE October 27, 2026

ACME UNITED REPORTS THIRD QUARTER 2026 NET SALES INCREASE OF 18%

SHELTON, CT – October 27, 2026 – Acme United Corporation (NYSE American: ACU) today announced that net sales for the quarter ended September 30, 2026, were $58.0 million compared to $49.1 million for the same period in 2025, an increase of 18%. Excluding sales resulting from the acquisition of the assets of My Medic on January 15, 2026, comparable three-month sales increased 10%. Net sales for the nine months ended September 30, 2026, were $173.0 million, compared to $149.0 million in the same period in 2025, an increase of 16%. Excluding My Medic sales, comparable nine-month sales increased 8%.

Net income was $3.4 million, or $0.80 per diluted share, for the quarter ended September 30, 2026, compared to $1.9 million, or $0.46 per diluted share, for the same period in 2025, an increase of 80% in net income and 74% in diluted earnings per share.

ACME UNITED CORPORATION NEWS RELEASE Bull 3 Bear 0 Results

CONTACT: Paul G. Driscoll Acme United Corporation 1 Waterview Drive Shelton, CT 06484

Phone: (203) 254-6060

FOR IMMEDIATE RELEASE July 23, 2026

ACME UNITED REPORTS SECOND QUARTER 2026 NET SALES INCREASE OF

16% AND NET INCOME INCREASE OF 6%

SHELTON, CT – July 23, 2026 – Acme United Corporation (NYSE American: ACU) today announced that net sales for the quarter ended June 30, 2026 were $62.7 million compared to $54.0 million for the quarter ended June 30, 2025, an increase of 16%. Excluding sales resulting from the acquisition of the assets of My Medic on January 15, 2026, comparable three-month sales increased 8%. Net sales for the six months ended June 30, 2026 were $115.0 million, compared to $100.0 million in the same period in 2025, an increase of 15%. Excluding My Medic sales, comparable six-month sales increased 7%.

Net income was $5.1 million, or $1.22 per diluted share, for the quarter ended June 30, 2026, compared to $4.8 million, or $1.16 per diluted share, for the same period last year, an increase of 6% in net income and 5% in diluted earnings per share.

The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

ITEM 2.03. CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT.

The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

Exhibit Number

Description

10.1

Credit Agreement with HSBC Bank USA, N.A. dated as of July 15, 2026

10.2

Revolving Note with HSBC Bank USA, N.A. dated as of July 15, 2026

10.3

Revolving Note with City National Bank dated as of July 15, 2026

10.4

Security Agreement with HSBC Bank USA, N.A. dated as of July 15, 2026

104

Prompts

Acme United Corporation. (ticker ACU), listed in United States.

ETFs Holding Acme United Corporation.

ETF Weight in ETF Shares Market value As of
AVUV 0.02% 105,883 $ 7.044M Nov 16, 2026
AVSC 0.02% 7,551 $ 502.368K Nov 16, 2026
BSVO 0.02% 6,137 $ 410K Nov 18, 2026
DFAT 0.01% 45,608 $ 3.203M Nov 12, 2026
DFSV 0.01% 37,853 $ 2.658M Nov 12, 2026
DFAS 0.01% 28,827 $ 2.024M Nov 12, 2026
DXUV 0.00% 1,925 $ 135.174K Nov 12, 2026
EBI 0.00% 116 $ 7,229.12 Aug 31, 2026
DFSU 0.00% 277 $ 19.451K Nov 12, 2026
DCOR 0.00% 4,797 $ 336.845K Nov 12, 2026
DFAC 0.00% 9,031 $ 634.157K Nov 12, 2026
DFUV 0.00% 1,030 $ 72.327K Nov 12, 2026
DFUS 0.00% 400 $ 28.088K Nov 12, 2026
AVUS 0.00% 464 $ 30.87K Nov 16, 2026